Attana will present at Redeye’s theme day for Diagnostics on the September 27 at 09.50

On September 27, Attana will participate in Redeye’s theme day for Diagnostics. Teodor Aastrup, CEO of Attana, will hold a company presentation followed by a Q&A session.

Attana will hold a 12-minute presentation followed by a 8-minute Q&A session. The event will be held at Redeye’s office but can also be accessed online via Redeye’s website.

A link to the live feed together with an agenda for Attana's presentation will be shared in a coming press release.

When: September 27 at 09.50

Where: Redeye, Mäster Samuelsgatan 42, Stockholm or online via Redeye’s website (link to be shared in coming press release)

For more information, please contact:

Teodor Aastrup, CEO
teodor.aastrup@attana.com
+46 (0)8 674 57 00

The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share price but is of general interest for the shareholders and hence should be communicated.

About Attana

Attana was founded in 2002 with the vision of in vitro characterization of molecular interactions mimicking in vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit www.attana.com or contact sales@attana.com